David J. Lederer, MD, MS, and Ganesh Raghu, MD, FACP, FCCP discuss the recent ATS guidelines.

Upon completion of this course, the participants should be able to:

  • Discuss the efficacy, safety, and clinical application of new treatment options in patients with IPF

Play